Mark your calendar for 2019
4th Annual Oligonucleotide Therapeutics: Discovery, Development and Delivery
March 26-28, 2019 * Hyatt Regency Cambridge * Cambridge, Massachusetts

OPT BOSTON Grows by more than 10% in 2018!
Attended by more than 150 unique companies

The Third Annual “Oligonucleotide & Peptide Therapeutics Boston” (OPT BOSTON)
was held March 26-28, 2018 at the Boston Marriott Cambridge, in Cambridge, Massachusetts.

More than 200 industry leaders from 17 different countries joined the 3 day discussions covering important issues related to the advances in the discovery, development and delivery of next-generation oligonucleotide and peptide therapies. This three-day event included two main conferences covering topics within discovery, clinical development, delivery, formulation and manufacturing, as well as a symposium focused on rare diseases.

The congress grew in attendance by 10% over last year. Also, participation was represented well with 52% attended by executives. With more than 60% of the audience from biotech, another 20% from pharma, and the event represented by 150+ unique organizations, this event will continue to gather a diverse body of attendees from around the world to network, share ideas, and discuss cutting-edge science and technology.

2018 Event Features

• 200+ Participants
• 2 Conferences
• 1 Symposium
• 1 Dinner Course
• Poster Sessions
• Dedicated Exhibit Hall Hours and Networking Functions

2018 Programs